While no clear link has been established between autism spectrum disorder and narcolepsy, shared neurological pathways may underlie overlapping symptoms and dual diagnosis. Narcolepsy is a ...

SAN DIEGO — The investigational drug AXS-12 (reboxetine, Axsome Therapeutics) is safe and effective for the treatment of cataplexy (emotionally induced muscle weakness) and excessive daytime ...

Narcolepsy, with or without cataplexy, can have a substantial detrimental effect on well-being and quality of life. Because there is no cure for this condition, current treatments aim to improve ...

Narcolepsy, a neurological disorder affecting sleep-wake cycles, impacts one in two thousand people, typically between ages ...

Hypersomnia and narcolepsy are both sleep disorders that cause excessive daytime sleepiness and other changes in natural sleep-wake cycles. "Hypersomnia" actually refers to several sleep conditions ...

Get inspired by a weekly roundup on living well, made simple. Sign up for CNN’s Life, But Better newsletter for information and tools designed to improve your well-being. Matthew Horsnell began ...

The US Food and Drug Administration (FDA) has approved Avadel Pharmaceuticals’ supplemental new drug application for extended-release sodium oxybate (Lumryz) for treatment of cataplexy or excessive ...

Narcolepsy is caused by a deficiency of orexin, a brain chemical that regulates wakefulness and REM sleep. The MSLT and polysomnography are gold standards for diagnosing narcolepsy. Medications like ...

People with narcolepsy often need to take medicines to manage their symptoms. Many of these medicines carry a high risk for abuse or misuse, so there are restrictions on how they are prescribed and ...

People with certain types of long-term sleep disorders may use a medicine called sodium oxybate to help treat their condition. This medicine is taken at night and may help people with narcolepsy to ...

Narcolepsy was linked to high blood pressure, hyperlipidemia, and diabetes on top of outright cardiovascular disease events in a retrospective cohort study. Notably, patients with narcolepsy started ...

Aaron Schokman is a member of the Sleep Health Foundation’s Consumer Reference Council. He has also received funding from the American Academy of Sleep Medicine Foundation for narcolepsy related ...